Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Hemcheck Sweden AB (publ) (HEMC.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
Add to watchlist
0.5040+0.0260 (+5.44%)
At close: 02:32PM CEST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4780
Open0.5200
Bid0.4470 x 0
Ask0.5000 x 0
Day's Range0.4430 - 0.5200
52 Week Range0.4310 - 2.5400
Volume11,503
Avg. Volume44,775
Market Cap16.016M
Beta (5Y Monthly)0.41
PE Ratio (TTM)N/A
EPS (TTM)-0.7300
Earnings DateNov 20, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for HEMC.ST

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      Hemcheck receives order from research program in the United States

      Hemcheck Sweden AB has received an order from the AREVA research program in the US. The order is a first order, is of minor economical value and is intended for research use. AREVA is a research program of The Geneva Foundation, which is a non-profit organization focused on research, development, and education in military medicine. AREVA collaborates with private organizations, academic institutions and with government agencies and organisations such as the US military and the FDA.

    • PR Newswire

      Hemcheck receives order from Czech distributor intended for university hospital in Prague

      Hemcheck Sweden AB has received an order from Promedica, a Czech distributor. The order is of lower economic value, concerns bgs-Test for diagnostic use and the end customer is the General University Hospital in Prague.

    • PR Newswire

      Hemcheck receives follow up order from its Greek distributor

      Hemcheck Sweden AB has today received a first follow-up order from its Greek distributor Antisel. The order is of lower economic value but shows that Antisel is active in the market and that Greek customers are in demand of Hemcheck's products.

    Advertisement
    Advertisement